The global inhalable drugs market size is expected to reach over USD 52.4 billion by 2030, according to a new report by Grand View Research, Inc., registering a CAGR of 6.6% from 2023 to 2030. Rising prevalence of respiratory diseases and increasing geriatric population are some of the key factors expected to drive the market. Chronic obstructive pulmonary disease (COPD) is a...